Cardiff Oncology's total assets for Q2 2026 were $37.33M, a decrease of -24.08% from the previous quarter. DE:XE7C total liabilities were $10.80M for the fiscal quarter, a -25.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.